(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ALVRANT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ALVRANT

ST13

US500000079263055

Class

5

Filing

79263055

Registration

5917460

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

07/07/2026

Trademark type

Word

Nice classes

5

Filing date

05/16/2019

Registration date

11/26/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/12/2026

Last transaction

07/07/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

GB

Examiner

ZAK, HENRY

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Glaxo Group Limited

Representatives

Legal Brand Protection, GlaxoSmithKline

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; vaccines

Publications

History of USPTO decisions and trademark events.

15 publications found

C71T

CANCELLED SECTION 71

06/12/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/23/2025

GPNX

NOTIFICATION PROCESSED BY IB

02/07/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/23/2020

FIMP

FINAL DISPOSITION PROCESSED

01/23/2020

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

12/26/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

11/26/2019

PUBO

PUBLISHED FOR OPPOSITION

09/10/2019

NPUB

NOTICE OF PUBLICATION

08/21/2019

MAFR

APPLICATION FILING RECEIPT MAILED

08/06/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/05/2019

DOCK

ASSIGNED TO EXAMINER

08/01/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/31/2019

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

07/25/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/18/2019

Continuous trademark protection

Get notified about every new filing that threatens ALVRANT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.